STEM CELL REP:关节炎也要有疫苗啦?

2017-04-28 Heather_z727 来宝网

【重组干细胞对抗关节炎:旨在设计关节炎疫苗】研究人员使用基因编辑技术,重编小鼠干细胞来对抗关节炎引起的炎症以及其他慢性疾病。这些干细胞被称为智能细胞,它们会长成软骨细胞产生生物抗炎药,在理想情况下,它们可以取代关节炎软骨,同时保护由其他慢性炎症引起的组织损伤。此次研究由华盛顿大学圣路易斯医学院的研究人员和杜克大学的研究人员合作完成。首先,研究人员从小鼠的尾巴上取了一些皮肤细胞,并将它们转化为干细胞


【重组干细胞对抗关节炎:旨在设计关节炎疫苗】研究人员使用基因编辑技术,重编小鼠干细胞来对抗关节炎引起的炎症以及其他慢性疾病。这些干细胞被称为智能细胞,它们会长成软骨细胞产生生物抗炎药,在理想情况下,它们可以取代关节炎软骨,同时保护由其他慢性炎症引起的组织损伤。

此次研究由华盛顿大学圣路易斯医学院的研究人员和杜克大学的研究人员合作完成。首先,研究人员从小鼠的尾巴上取了一些皮肤细胞,并将它们转化为干细胞,接着,使用基因编辑工具在培养皿中将其培育,研究人员去除了一个与炎症有关的关键基因,并用一种可以释放天然抗炎药的基因加以取代。

此次研究的完整报告发表于4月27日《干细胞》在线杂志中。

研究人员在报道中指出:“我们的目的是作为关节炎的疫苗重新包装这些干细胞,使它们在关节需要的时候,自然输送天然生物抗炎药。为了做到这一步,我们需要把这些干细胞改造成智能细胞。”

目前,很多治疗关节炎的药物,比如依那西普,阿达木当康,类克等,都是在攻击促进炎症的分子,这些分子叫做肿瘤坏死因子-α,然而这些药物的缺点就在于它们的药效都是对于全身的,而不是仅仅靶向关节炎,结果,它们会干扰整个免疫系统,使病人体质变弱,易感染

“我们的研究旨在解决这一问题,更好的帮助关节炎患者。”

原始出处:

Brunger JM,Zutshi A, Willard VP, et al. Genome Engineering of Stem Cells for Autonomously Regulated, Closed-Loop Delivery of Biologic Drugs. STEM CELL REP. 2017 Apr 27.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1794482, encodeId=8dea1e944829a, content=<a href='/topic/show?id=82b416e79f5' target=_blank style='color:#2F92EE;'>#stem cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16779, encryptionId=82b416e79f5, topicName=stem cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed Aug 16 15:45:00 CST 2017, time=2017-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1869930, encodeId=813a186993016, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Feb 19 01:45:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1960189, encodeId=7d251960189b8, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Nov 28 09:45:00 CST 2017, time=2017-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265397, encodeId=bb52126539e3b, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Sun Apr 30 10:45:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481986, encodeId=398c14819865c, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Sun Apr 30 10:45:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=191998, encodeId=01ae191998cb, content=如果成功就好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRryoiaM3hYcC93J7aWyPQ4d7aKyTcCfpOkf1Le6znZg6FNLRvoNRXwCeYVDCcNUA1odC3oD8SlzQ8/0, createdBy=30281833508, createdName=hippoandxym1727, createdTime=Sun Apr 30 06:09:47 CST 2017, time=2017-04-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1794482, encodeId=8dea1e944829a, content=<a href='/topic/show?id=82b416e79f5' target=_blank style='color:#2F92EE;'>#stem cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16779, encryptionId=82b416e79f5, topicName=stem cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed Aug 16 15:45:00 CST 2017, time=2017-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1869930, encodeId=813a186993016, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Feb 19 01:45:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1960189, encodeId=7d251960189b8, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Nov 28 09:45:00 CST 2017, time=2017-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265397, encodeId=bb52126539e3b, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Sun Apr 30 10:45:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481986, encodeId=398c14819865c, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Sun Apr 30 10:45:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=191998, encodeId=01ae191998cb, content=如果成功就好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRryoiaM3hYcC93J7aWyPQ4d7aKyTcCfpOkf1Le6znZg6FNLRvoNRXwCeYVDCcNUA1odC3oD8SlzQ8/0, createdBy=30281833508, createdName=hippoandxym1727, createdTime=Sun Apr 30 06:09:47 CST 2017, time=2017-04-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1794482, encodeId=8dea1e944829a, content=<a href='/topic/show?id=82b416e79f5' target=_blank style='color:#2F92EE;'>#stem cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16779, encryptionId=82b416e79f5, topicName=stem cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed Aug 16 15:45:00 CST 2017, time=2017-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1869930, encodeId=813a186993016, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Feb 19 01:45:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1960189, encodeId=7d251960189b8, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Nov 28 09:45:00 CST 2017, time=2017-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265397, encodeId=bb52126539e3b, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Sun Apr 30 10:45:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481986, encodeId=398c14819865c, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Sun Apr 30 10:45:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=191998, encodeId=01ae191998cb, content=如果成功就好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRryoiaM3hYcC93J7aWyPQ4d7aKyTcCfpOkf1Le6znZg6FNLRvoNRXwCeYVDCcNUA1odC3oD8SlzQ8/0, createdBy=30281833508, createdName=hippoandxym1727, createdTime=Sun Apr 30 06:09:47 CST 2017, time=2017-04-30, status=1, ipAttribution=)]
    2017-11-28 维他命
  4. [GetPortalCommentsPageByObjectIdResponse(id=1794482, encodeId=8dea1e944829a, content=<a href='/topic/show?id=82b416e79f5' target=_blank style='color:#2F92EE;'>#stem cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16779, encryptionId=82b416e79f5, topicName=stem cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed Aug 16 15:45:00 CST 2017, time=2017-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1869930, encodeId=813a186993016, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Feb 19 01:45:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1960189, encodeId=7d251960189b8, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Nov 28 09:45:00 CST 2017, time=2017-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265397, encodeId=bb52126539e3b, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Sun Apr 30 10:45:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481986, encodeId=398c14819865c, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Sun Apr 30 10:45:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=191998, encodeId=01ae191998cb, content=如果成功就好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRryoiaM3hYcC93J7aWyPQ4d7aKyTcCfpOkf1Le6znZg6FNLRvoNRXwCeYVDCcNUA1odC3oD8SlzQ8/0, createdBy=30281833508, createdName=hippoandxym1727, createdTime=Sun Apr 30 06:09:47 CST 2017, time=2017-04-30, status=1, ipAttribution=)]
    2017-04-30 lmm397
  5. [GetPortalCommentsPageByObjectIdResponse(id=1794482, encodeId=8dea1e944829a, content=<a href='/topic/show?id=82b416e79f5' target=_blank style='color:#2F92EE;'>#stem cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16779, encryptionId=82b416e79f5, topicName=stem cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed Aug 16 15:45:00 CST 2017, time=2017-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1869930, encodeId=813a186993016, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Feb 19 01:45:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1960189, encodeId=7d251960189b8, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Nov 28 09:45:00 CST 2017, time=2017-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265397, encodeId=bb52126539e3b, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Sun Apr 30 10:45:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481986, encodeId=398c14819865c, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Sun Apr 30 10:45:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=191998, encodeId=01ae191998cb, content=如果成功就好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRryoiaM3hYcC93J7aWyPQ4d7aKyTcCfpOkf1Le6znZg6FNLRvoNRXwCeYVDCcNUA1odC3oD8SlzQ8/0, createdBy=30281833508, createdName=hippoandxym1727, createdTime=Sun Apr 30 06:09:47 CST 2017, time=2017-04-30, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1794482, encodeId=8dea1e944829a, content=<a href='/topic/show?id=82b416e79f5' target=_blank style='color:#2F92EE;'>#stem cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16779, encryptionId=82b416e79f5, topicName=stem cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed Aug 16 15:45:00 CST 2017, time=2017-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1869930, encodeId=813a186993016, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Feb 19 01:45:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1960189, encodeId=7d251960189b8, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Nov 28 09:45:00 CST 2017, time=2017-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265397, encodeId=bb52126539e3b, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Sun Apr 30 10:45:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481986, encodeId=398c14819865c, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Sun Apr 30 10:45:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=191998, encodeId=01ae191998cb, content=如果成功就好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRryoiaM3hYcC93J7aWyPQ4d7aKyTcCfpOkf1Le6znZg6FNLRvoNRXwCeYVDCcNUA1odC3oD8SlzQ8/0, createdBy=30281833508, createdName=hippoandxym1727, createdTime=Sun Apr 30 06:09:47 CST 2017, time=2017-04-30, status=1, ipAttribution=)]
    2017-04-30 hippoandxym1727

    如果成功就好了

    0

相关资讯

以关节炎为首发表现的肥大性肺性谷关节病

肥大性骨关节病(HOA)是由MARIE和BAMBERGER于19世纪后期首先报道,故又称Marie-Bamberger综合征,是以管状骨骨膜炎、杵状指(趾)和肢体疼痛或肿胀为特征的骨关节病变。分为原发性和继发性,原发性HOA少见,主要见于儿童,为家族遗传性;继发性HOA相对多见,常见于成年人,多由胸腔内疾病所致,也称为肥大性肺性骨关节病(HOPA)。80%HOPA继发于肺部恶性肿瘤,包括原发性肺癌

J Clin Periodontol:风湿性关节炎和牙周炎患者体内可以产生抗瓜氨酸组蛋白H3的自身抗体

这篇研究的目的是为了检测有炎症的牙周组织中是否存在瓜氨酸组蛋白的表达,以及在风湿性关节炎(RA)和牙周炎(PD)患者中检测是否存在抗瓜氨酸组蛋白的抗体。

女人如水,可是女人也更易患关节炎

为什么如水般的女人更容易患关节炎?近日,科学家们似乎找到了其根源,他们发现了一个基因“总开关”。专家称,这种控制免疫系统基因的发现为靶向的药物的开发铺平了道路。大约有80%的自体免疫疾病患者是女性,自体免疫疾病是一种人体内自己的免疫系统攻击正常细胞的疾病,使正常的免疫能力下降,而异常的免疫能力却突显的一种问题。尽管这种疾病的性别差异非常明显,但是研究人员们仍然不清楚原因是什么。现在,美国密歇根大学

一文读懂:近期关节炎相关学术成果

关节炎泛指发生在人体关节及其周围组织的炎性疾病,可分为数十种。我国的关节炎患者有1亿以上,且人数在不断增加。近日,英国国家卫生与临床优化研究所(NICE)已发布最终指南,支持将Cosentyx用于英国国家卫生服务系统(NHS),作为一种单药疗法或联合甲氨蝶呤(MTX),用于既往接受肿瘤坏死因子α(TNF-α)抑制剂治疗但在治疗12周后病情停止缓解、以及不适合接受TNF-α抑制剂治疗的活动性银屑

LANCET:甲氨蝶呤能否增加关节内皮质类固醇对幼年关节炎的疗效?

\目前,很少有基于证据的信息可用于指导治疗低聚幼年特发性关节炎。近期,一项发表在权威杂志LANCET上的文章研究了口服甲氨蝶呤能否增加关节内皮质类固醇的疗效。这是一项在意大利十家医院进行的前瞻性、开放性、随机试验。将18岁以下的患病儿童随机分配(1:1)分为单独关节内予以皮质类固醇或与口服甲氨蝶呤组合(15mg / m 2;最大20mg)两组。使用的皮质类固醇是曲安奈德(肩、肘、腕、膝和胫骨关节)

NEJM:阿达木单抗用于儿童和青少年活动性特发性关节炎相关的葡萄膜炎

阿达木单抗可有效控制炎症并提高儿童和青少年活动性特发性关节炎相关葡萄膜炎的治疗效果